#pharmaceutical-sector
Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr
Specialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with an open offer for an additional 26%. This strategic move aims to strengthen Anupam Rasayan's presence across the pharmace…
Chemical Licensing Industry Report 2026: Global Market to Surpass $35 Billion in 2031, Driven by the Expansion and Technological Demands of Key End-use Industries
Key opportunities in the chemical licensing market are driven by demand in advanced manufacturing, particularly in the C2 value chain and the pharmaceutical sector. The Asia-Pacific region leads growth, fueled by industrialization and investment in integrated…